Clinical pharmacists participating in pharmaceutical consultation of one case of disseminated neonatal herpes simplex virus type Ⅱ infection

LI Na; ZOU Ze; PENG Fabing; WANG Xin; LI Fei; XIE Qian

doi:10.6039/j.issn.1001-0408.2022.21.21

您当前的位置：

首页 >

文章列表页 >

Clinical pharmacists participating in pharmaceutical consultation of one case of disseminated neonatal herpes simplex virus type Ⅱ infection

更新时间：2023-02-22

- Clinical pharmacists participating in pharmaceutical consultation of one case of disseminated neonatal herpes simplex virus type Ⅱ infection
- ZHONGGUO YAOFANG Vol. 33, Issue 21, Pages: 2676-2680(2022)
- 作者机构：
  
  1.重庆市黔江中心医院药学部，重庆　409099
  2.重庆市黔江中心医院新生儿科，重庆　409099
  3.重庆市黔江中心医院产科，重庆　409099
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2022.21.21
  CLC： R969.3
- Published：15 November 2022，
  
  Received：28 July 2022，
  
  Revised：27 September 2022，
扫描看全文
李娜,邹泽,彭发兵等.临床药师参与1例新生儿播散性Ⅱ型单纯疱疹病毒感染的药学会诊 ^Δ[J].中国药房,2022,33(21):2676-2680.

LI Na,ZOU Ze,PENG Fabing,et al.Clinical pharmacists participating in pharmaceutical consultation of one case of disseminated neonatal herpes simplex virus type Ⅱ infection[J].ZHONGGUO YAOFANG,2022,33(21):2676-2680.
李娜,邹泽,彭发兵等.临床药师参与1例新生儿播散性Ⅱ型单纯疱疹病毒感染的药学会诊 ^Δ[J].中国药房,2022,33(21):2676-2680. DOI： 10.6039/j.issn.1001-0408.2022.21.21.

LI Na,ZOU Ze,PENG Fabing,et al.Clinical pharmacists participating in pharmaceutical consultation of one case of disseminated neonatal herpes simplex virus type Ⅱ infection[J].ZHONGGUO YAOFANG,2022,33(21):2676-2680. DOI： 10.6039/j.issn.1001-0408.2022.21.21.

摘要

本文介绍了临床药师参与1例首发症状为发热且不伴皮肤黏膜受累表现的新生儿播散性Ⅱ型单纯疱疹病毒感染的诊治过程。临床药师通过评估患儿病情，到产科了解患儿母亲病史和用药情况，查阅文献资料，分析患儿发热可能与其母亲病史相关，考虑患儿存在新生儿HSV感染可能，建议完善病毒相关检测后即刻予静脉注射阿昔洛韦20 mg/kg，q8 h抗病毒治疗，并密切监测阿昔洛韦常见的不良反应。医师接受会诊建议。患儿确诊新生儿播散性Ⅱ型HSV感染，经治疗，患儿病情相对稳定，医师再次请临床药师会诊协助制定患儿后续药物治疗方案和监护计划。临床药师参考相关文献，建议静脉用阿昔洛韦21 d后，再口服阿昔洛韦300 mg/m

，q8 h治疗6个月，且在口服用药期间继续监测其常见不良反应，并随访评估患儿神经系统发育等情况。医师采纳药师意见。患儿静脉用阿昔洛韦期间未出现不良反应，好转出院后口服阿昔洛韦第4周出现血肌酐和尿素升高，停药后恢复正常。患儿随访至1岁，预后良好，未出现神经系统后遗症。临床药师通过参与药学会诊，协助临床医师明确了治疗策略，降低了新生儿的用药风险，在药物治疗过程中发挥了积极有效的作用，体现了临床药师在多学科协作诊疗中的职业价值。

Abstract

This paper describes the clinical pharmacists’ participation in the diagnosis and treatment for a case of disseminated neonatal herpes simplex virus （HSV） type Ⅱ infection with fever as the initial symptom and without skin and mucous membrane involvement. Clinical pharmacists assessed the newborn’s condition， inquired about the disease history and medication status of the child’s mother hospitalized in the department of obstetrics， reviewed the literature， analyzed that the fever of the child might be related to the medical history of the mother， and considered that the child might have neonatal HSV infection. It was suggested to use acyclovir 20 mg/kg intravenously for q8 h immediately after completing virus-related testing， and closely monitor the common adverse drug reactions of acyclovir. The doctors accepted the consultation advice. The newborn was diagnosed as disseminated neonatal HSV type Ⅱ infection. After treatment， the child’s condition was relatively stable and the doctors consulted clinical pharmacists again to help formulate the follow-up drug treatment plan and monitoring plan for the patient. After reviewing relevant literature， clinical pharmacists suggested that after 21 days of intravenous acyclovir treatment， oral acyclovir 300 mg/m

q8 h should be continued for 6 months； moreover， common adverse drug reactions should be monitored and neurological development should be evaluated during oral acyclovir treatment， all of which were accepted by physicians. No adverse drug reactions occurred during intravenous administration of acyclovir， serum creatinine and urea increased in the 4th week of oral acyclovir administration， but returned to normal after drug withdrawal. The baby was followed up to 1 year old， and the prognosis was good without neurological sequelae. Clinical pharmacists enabled the clinicians to clarify the treatment strategy and also reduced the risk of medication for the patient by participating in the pharmaceutical consultation. Clinical pharmacists play an active and effective role in the medication treatment， which fully embodies the professional value in multidisciplinary collaborative diagnosis and treatment.

关键词

Ⅱ型单纯疱疹病毒临床药师药学会诊新生儿

Keywords

clinical phar- macistspharmaceutical consulta- tionnewborn

references

JAISHANKAR D，SHUKLA D. Genital herpes：insights into sexually transmitted infectious disease[J].Microb Cell，2016，3（9）：438-450.

邵肖梅，叶鸿瑁，丘小汕.实用新生儿学[M]. 5版.北京：人民卫生出版社，2019：485-488.

LOOKER K J，MAGARET A S，MAY M T，et al. First estimates of the global and regional incidence of neonatal herpes infection[J].Lancet Glob Health，2017，5（3）：e300-e309.

POOLE C L，KIMBERLIN D W. Antiviral approaches for the treatment of herpes simplex virus infections in newborn infants[J].Annu Rev Virol，2018，5（1）：407-425.

COREY L，WALD A. Maternal and neonatal herpes simplex virus infections[J].N Engl J Med，2009，361（14）：1376-1385.

KIMBERLIN D W，WHITLEY R J，WAN W，et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes[J].N Engl J Med，2011，365（14）：1284-1292.

SAMIES N L，JAMES S H. Prevention and treatment of neonatal herpes simplex virus infection[J].Antiviral Res，2020，176：104721.

魏家凯，赵玉娟，陈璐.全身播散型新生儿单纯疱疹病毒感染七例临床分析[J].中华新生儿科杂志，2021，36（3）：42-45.

BASINGER J M，FIESTER S E，FULCHER J W. Morta- lity from neonatal herpes simplex viremia causing severe hepatitis[J].Forensic Sci Med Pathol，2019，15（4）：663-666.

刘为贱，李洪亮，胡建.单纯疱疹病毒感染新生儿血液微量元素的变化[J].广东微量元素科学，2015，22（6）：19-21.

郁飞，郭敏，钟天鹰.单纯疱疹病毒感染新生儿血液微量元素的变化[J].临床儿科杂志，2010，28（6）：557-559.

赵海燕，李坚.新生儿单纯疱疹病毒中枢神经系统感染病例报告并文献复习[J].广州医药，2021，52（1）：100-104.

赵媛，刘克战，王成虎，等.新生儿单纯疱疹病毒感染二例报道并文献复习[J].中国小儿急救医学，2018，25（2）：158-160.

陈仁贵，钱黎华，张定国，等.新生儿单纯疱疹病毒感染1例[J].临床皮肤科杂志，2003，32（11）：659-660.

JAMES S H，KIMBERLIN D W. Neonatal herpes simplex virus infection：epidemiology and treatment[J].Clin Perinatol，2015，42（1）：47-59，Ⅷ.

KIMBERLIN D W，LIN C Y，JACOBS R F，et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era[J].Pediatrics，2001，108（2）：223-229.

BROWER L H，WILSON P M，MURTAGH KUROWSKI E，et al. Using quality improvement to implement a standardized approach to neonatal herpes simplex virus[J].Pediatrics，2019，144（2）：e20180262.

MULLER W J，ZHENG X T. Laboratory diagnosis of neonatal herpes simplex virus infections[J].J Clin Microbiol，2019，57（5）：e01460-e01418.

KUKHANOVA M K，KOROVINA A N，KOCHETKOV S N. Human herpes simplex virus：life cycle and development of inhibitors[J].Biochemistry（Mosc），2014，79（13）：1635-1652.

BIRKMANN A，ZIMMERMANN H. HSV antivirals： current and future treatment options[J].Curr Opin Virol，2016，18：9-13.

WANG Y，SMITH K P. Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection[J].J Pediatr Pharmacol Ther，2014，19（2）：72-82.

杨荷丹，蒋娟.单纯疱疹病毒感染的复发机制与治疗的研究进展[J].中国麻风皮肤病杂志，2018，34（11）：694-697.

YARLAGADDA S G，PERAZELLA M A. Drug-induced crystal nephropathy：an update[J].Expert Opin Drug Saf，2008，7（2）：147-158.

SUGIMOTO K，KENZAKA T，SUGIMOTO R，et al. Encephalopathy induced by preventive administration of acyclovir in a man with symptomatic multiple myeloma and renal dysfunction[J].Int J Gen Med，2021，14：413-417.

陈美钦.阿昔洛韦群体药动学研究进展[J].海峡药学，2015，27（12）：7-9.

KIMBERLIN D W，JACOBS R F，WELLER S，et al. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age[J]. Clin Infect Dis，2010，50（2）：221-228.

杨华，魏晶，王嘉仡，等.药品不良反应/事件报告评价方法研究[J].中国药物警戒，2009，6（10）：581-584.

温宁绥.临床药师参与妊娠期泛发性脓疱型银屑病会诊1例[J].中国现代应用药学，2020，37（23）：2907-2912.

陈银清，吴玮哲，何艳玲，等.临床药师参与1例声门下区马尔尼菲蓝状菌感染患儿的药学监护[J].中国药房，2020，31（12）：1511-1515.

张淑兰，吴燕子，甘永祥.循证医学思想对临床药学工作的启示[J].中国医院药学杂志，2011，31（4）：329-331.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

我院2011年新生儿血源性感染凝固酶阴性葡萄球菌菌种分布及耐药性分析

我院新生儿科胎膜早破患儿预防感染应用抗菌药物分析

新生儿内科住院患儿超说明书用药情况分析

我院2013年1－10月早发型与晚发型新生儿败血症细菌耐药性及抗菌药物使用分析

我院新生儿静脉用药集中调配工作模式的建立及成效

Related Author

张海琼俞小珍

杨华良田秀英邢　丽

史　强王晓玲王　巍张　建

许银燕黄新艳谢娟陈燕妮傅菁王俐

朱石秀邱日想张雅溶司徒冰

赵静马晓博冯锐丁翔宇

罗德凤祁兢晶邹振红

凡小燕

Related Institution

No data

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰